Special Issue "The Progress on Pharmaceutics in Drug Delayed Release System"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (31 July 2011)
Prof. Dr. Neal M. Davies (Website)
Faculty of Pharmacy, University of Manitoba, Apotex Centre, 750 McDermot Avenue, Winnipeg, Manitoba R3E OT5, Canada
Fax: +1 509 335 5902
Interests: pharmacokinetics; chirality; drug interactions; formulation and drug delivery
It is often important to maintain therapeutic plasma concentrations for drugs exhibiting a short terminal half-life; for this, dosage forms with a lower input rate have been developed and pharmaceutical manufacturing of controlled, extended, and sustained release formulations have developed and evolved. With the advent of a variety of new delivery platforms and systems, formulations, biomaterials, technologies and a plethora of exciting selected therapeutic approaches significant progress on the pharmaceutics of drug delayed release systems has ensued. Therapeutic delivery of macromolecules is evolving with the aim of controlling absorption, distribution, metabolism, and cellular uptake through programmed drug delivery. Specifically, drug targeting by carriers utilizing pro-drugs, synthetic polymers, lipids, and various nanocarrier approaches is becoming more frequently incorporated into drug controlled release systems. This alteration and manipulation of input and output rates of drugs is becoming increasingly complex and drug delivery has evolved in advancing and altering release. This special issue serves to highlight and capture a variety of advances and illustrate the remaining challenges of contemporary progress in the pharmaceutics of drug modified release systems. We invite articles on all aspects of pharmaceutics in drug delayed release systems for this special issue.
Prof. Dr. Neal M. Davies
- drug delivery
- drug release
- drug formulation
- dosage forms
- Nanocarrier technologies
- Sustained release
- delayed release
- modified release